不同的抗VEGF药物的相对有效性和安全性,与不同输送方法相结合,用于神经血管绿内障:系统性审查和贝叶斯网络元分析
Jiaqi Wang1, Yi-Ming Guo1, Junhan Wei1
1Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi, China.
BMJ open
|March 5, 2024
概括
同时注射conbercept (ICCIVC) 的内内和内腔内注射是治疗新血管玻璃眼 (NVG) 的最有效和最安全的方法. 与其他抗VEGF药物相比,这种组合疗法提供了优越的眼内压力降低.
科学领域:
- 眼科医生 眼科 眼科
- 血管生物学 血管生物学
- 玻璃眼研究研究 玻璃眼研究
背景情况:
- 新血管玻璃眼 (NVG) 是一种严重的疾病,其特点是虹膜和前腔中异常的血管生长,导致眼内压力升高 (IOP).
- 抗血管内皮生长因子 (VEGF) 药物在通过抑制病态血管生成来控制NVG方面至关重要.
- 最佳的药物输送方法和药剂选择对于最大限度地提高NVG治疗的治疗效果和安全性至关重要.
结论:
- ICCIVC成为NVG的优越治疗策略,在有效性和安全性方面优于其他抗VEGF疗法.
- 结合内和室内给药途径,加上conbercept,是NVG管理中最有效的方法.
- 该NMA提供了强有力的证据,支持ICCIVC作为新血管绿内障患者首选的治疗选择.
相关概念视频
Open Angle Glaucoma: Treatment
448
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
448
Angle Closure Glaucoma: Treatment
493
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
493
Drug Delivery: Miscellaneous Routes
338
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
338


